Related Experiment Video
Updated: Dec 24, 2025
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Diagnostic imaging and therapeutic application of nanoparticles targeting the liver
Haolu Wang1, Camilla A Thorling, Xiaowen Liang
1Therapeutics Research Centre, School of Medicine, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, QLD 4102, Australia. xin.liu@uq.edu.au m.roberts@uq.edu.au.
Abstract:
Liver diseases, particularly viral hepatitis, cirrhosis and hepatocellular carcinoma, are common in clinical practice with high morbidity and mortality worldwide. Many substances for diagnostic imaging and therapy of liver diseases may have either severe adverse effects or insufficient effectiveness in vivo because of their nonspecific uptake. Therefore, by targeting the delivery of drugs into the liver or specific liver cells, drug efficiency may be largely improved. This review summarizes the up-to-date research progress focusing on nanoparticles targeting the liver for both diagnostic and therapeutic purposes. Targeting strategies, mechanisms of enhanced effects, and clinical applications of nanoparticles are discussed specifically. We believe that new targeting nanotechnology such as nanoprobes for multi-modality imaging and multifunctional nanoparticles would facilitate significant advancements in this active research area in the near future.
Insights
Nanoparticles targeting the liver offer improved diagnostic and therapeutic options for liver diseases like viral hepatitis and cancer. This review explores targeting strategies and future advancements in nanomedicine for liver health.
Area of Science:
- Hepatology and Nanomedicine
Background:
- Liver diseases, including viral hepatitis, cirrhosis, and hepatocellular carcinoma, present significant global health challenges with high morbidity and mortality.
- Current diagnostic and therapeutic agents for liver conditions often suffer from nonspecific uptake, leading to adverse effects or limited efficacy.
- Targeted drug delivery to the liver or specific liver cells holds promise for enhancing treatment effectiveness.
Purpose of the Study:
- To review current research on nanoparticles designed for liver targeting.
- To discuss strategies and mechanisms for enhancing diagnostic and therapeutic outcomes in liver diseases using targeted nanoparticles.
- To explore the clinical applications and future potential of liver-targeting nanomedicine.
Main Methods:
- Comprehensive literature review of studies focusing on nanoparticle-based liver targeting.
- Analysis of various targeting strategies, including passive and active targeting mechanisms.
- Examination of research on nanoparticles for both diagnostic imaging and therapeutic interventions in liver diseases.
Main Results:
- Nanoparticle-based approaches demonstrate potential for improved drug delivery and reduced toxicity in liver disease treatment.
- Targeting strategies enhance the specificity of diagnostic probes and therapeutic agents within the liver.
- Emerging nanotechnologies, such as multi-modality imaging nanoprobes and multifunctional nanoparticles, are advancing the field.
Conclusions:
- Targeted nanoparticle delivery represents a promising strategy to overcome limitations of conventional treatments for liver diseases.
- Further development of nanotechnology, including advanced nanoprobes and multifunctional nanoparticles, is expected to drive significant progress in liver disease diagnosis and therapy.
- Nanomedicine offers a pathway to more effective and safer management of prevalent liver conditions.
